Literature DB >> 16760118

Familial voluntary nystagmus.

Birte Neppert1, Holger Rambold.   

Abstract

PURPOSE: To examine the pathological significance and familial occurrence of voluntary nystagmus. PATIENTS AND METHODS: We examined two families orthoptically as well as with video and search-coil techniques or electronystagmography (ENG). Three members of three generations of the first family and a 9-year-old boy from a second family not related to the first were able to generate a voluntary horizontal nystagmus.
RESULTS: The characteristics of the nystagmus of our original patient, his daughter and 8-year-old grandson (1st family) were remarkably similar: duration of 2-5 seconds, amplitudes of 1-4 degrees and frequencies around 15 cycles/second. In the second family, our patient with a congenital esotropia and hyperopia was the only one of his family who could voluntarily produce a nystagmus of about 5 degrees and 10 cycles/second for maximum of 20 seconds. During prolonged reading, the same nystagmus with disturbing oscillopsia developed involuntarily and was not suppressible. We added +0.75 diopters to both lenses of his spectacles to account for the result of our cycloplegic refraction. This stopped the involuntary nystagmus during near fixation. DISCUSSION: To avoid unintentional "bouts" of voluntary nystagmus, a reduction of the convergence impulse by plus-lenses may be effective. The parameters of voluntary nystagmus can be considered family-specific.

Entities:  

Mesh:

Year:  2006        PMID: 16760118     DOI: 10.1080/09273970600701226

Source DB:  PubMed          Journal:  Strabismus        ISSN: 0927-3972


  2 in total

1.  Saccadic oscillations - membrane, model, and medicine.

Authors:  Aasef G Shaikh
Journal:  Expert Rev Ophthalmol       Date:  2012-10

Review 2.  Saccadic burst cell membrane dysfunction is responsible for saccadic oscillations.

Authors:  Aasef G Shaikh; Stefano Ramat; Lance M Optican; Kenichiro Miura; R John Leigh; David S Zee
Journal:  J Neuroophthalmol       Date:  2008-12       Impact factor: 3.042

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.